Fulgent Genetics, Inc. Gross Profit

Quick Answer

Fulgent Genetics, Inc. reported Gross Profit of $130.88 million for the year ending 2025.

  • Fulgent Genetics, Inc. showed an increase of +22.1% in Gross Profit from 2024 to 2025.
  • This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: $935.0 thousand | Q2 2015: $1.41 million | Q3 2015: $1.99 million | Q4 2015: $175.0 thousand | Q1 2016: $2.14 million | Q2 2016: $2.56 million | Q3 2016: $2.87 million | Q4 2016: $3.99 million | Q1 2017: $3.45 million | Q2 2017: $2.76 million | Q3 2017: $2.24 million | Q4 2017: $1.74 million | Q1 2018: $1.88 million | Q2 2018: $2.86 million | Q3 2018: $3.01 million | Q4 2018: $2.90 million | Q1 2019: $2.40 million | Q2 2019: $4.80 million | Q3 2019: $6.46 million | Q4 2019: $4.75 million | Q1 2020: $3.70 million | Q2 2020: $9.55 million | Q3 2020: $75.46 million | Q4 2020: $243.21 million | Q1 2021: $285.35 million | Q2 2021: $117.76 million | Q3 2021: $184.40 million | Q4 2021: $189.54 million | Q1 2022: $242.54 million | Q2 2022: $65.28 million | Q3 2022: $46.10 million | Q4 2022: $12.99 million | Q1 2023: $18.81 million | Q2 2023: $20.57 million | Q3 2023: $39.84 million | Q1 2024: $22.10 million | Q2 2024: $26.49 million | Q3 2024: $26.77 million | Q1 2025: $28.35 million | Q2 2025: $34.44 million | Q3 2025: $35.51 million.
  • Over the full 12 years of available data (2014 to 2025), Fulgent Genetics, Inc.'s Gross Profit has grown by 38,167.5%.
  • Historical annual values: Fiscal year 2025: $130.88 million | Fiscal year 2024: $107.22 million | Fiscal year 2023: $104.46 million | Fiscal year 2022: $366.90 million | Fiscal year 2021: $777.05 million | Fiscal year 2020: $331.91 million | Fiscal year 2019: $18.42 million | Fiscal year 2018: $10.65 million | Fiscal year 2017: $10.18 million | Fiscal year 2016: $11.55 million | Fiscal year 2015: $4.51 million | Fiscal year 2014: $342.0 thousand.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: